These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34684819)

  • 21. Ameliorative effects of echinacoside against spinal cord injury via inhibiting NLRP3 inflammasome signaling pathway.
    Gao S; Xu T; Guo H; Deng Q; Xun C; Liang W; Sheng W
    Life Sci; 2019 Nov; 237():116978. PubMed ID: 31644893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
    Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
    Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
    Jiang H; Gong T; Zhou R
    Adv Immunol; 2020; 145():55-93. PubMed ID: 32081200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
    Buckley LF; Libby P
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination.
    Chen H; Lin H; Xie S; Huang B; Qian Y; Chen K; Niu Y; Shen HM; Cai J; Li P; Leng J; Yang H; Xia D; Wu Y
    Toxicol Appl Pharmacol; 2019 Feb; 365():19-29. PubMed ID: 30594691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
    Kim JK; Jin HS; Suh HW; Jo EK
    Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation.
    Lee EH; Shin JH; Kim SS; Seo SR
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine attenuates depression-like behavior by modulating the hippocampal NLRP3 ubiquitination signaling pathway through Trim65.
    Yang L; Huang Y; Chen F; Wang Y; Su K; Zhao M; Tao W; Liu W
    Int Immunopharmacol; 2023 Oct; 123():110808. PubMed ID: 37595491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
    Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
    J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7.
    Kim SK; Choe JY; Park KY
    Biochem Biophys Res Commun; 2019 Sep; 517(2):338-345. PubMed ID: 31358323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytochemical Constituents of
    Buakaew W; Pankla Sranujit R; Noysang C; Thongsri Y; Potup P; Nuengchamnong N; Suphrom N; Usuwanthim K
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33466926
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent Progress on the Discovery of NLRP3 Inhibitors and their Therapeutic Potential.
    Su M; Wang W; Liu F; Li H
    Curr Med Chem; 2021; 28(3):569-582. PubMed ID: 31971103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin: an inflammasome silencer.
    Hasanzadeh S; Read MI; Bland AR; Majeed M; Jamialahmadi T; Sahebkar A
    Pharmacol Res; 2020 Sep; 159():104921. PubMed ID: 32464325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
    Takahashi M
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
    Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
    Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication.
    Jhang JJ; Lin JH; Yen GC
    J Agric Food Chem; 2018 Jan; 66(4):765-772. PubMed ID: 29293001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
    Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
    Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice.
    Zhai Y; Meng X; Ye T; Xie W; Sun G; Sun X
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.